NCT05936086
- Conditions
- Hemic and Lymphatic Diseases, Hemophagocytic Syndrome, Histiocytosis, +3 more
- Locations
-
- The Second affiliated Hosptial of Chongqing medical University Chongqing, China
Clinical trial condition
Histiocytosis
Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.
406 public trials
82 recruiting studies
Histiocytosis trial results
NCT03491605
- Conditions
- DNA Virus Infections, EBV Infection, Epstein-Barr Virus Infections, +9 more
- Locations
-
- Tongji hospital, Tongji medical collage of HUST Wuhan, Hubei, China
Not yet recruiting
Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement
NCT07812493
- Conditions
- CNS Involvement of Systemic Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT07443137
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +5 more
- Locations
-
Not specified
Not yet recruiting
Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma
NCT07744750
- Conditions
- CLL / SLL, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
- Locations
-
- Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Not yet recruiting
Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL
NCT07744737
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Not yet recruiting
Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL
NCT07744724
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Not yet recruiting
Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics
NCT07748364
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Disease Attributes, Hemic and Lymphatic Diseases, +18 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
Not yet recruiting
Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis
NCT07728201
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
- Locations
-
- Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China
Not yet recruiting
Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma
NCT07677813
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The First Bethune Hospital of Jilin University Changchun, Jilin, China